Publication | Closed Access

Safety and efficacy of Ombitasvir, Paritaprevir/Ritonavir and Dasabuvir with or without ribavirin in chronic hepatitis C patients receiving opioid substitution therapy: a pooled analysis across 12 clinical trials

Opioid EpidemicViral HepatitisMedicineClinical TrialsHepatitisAntiviral TherapyAddiction MedicinePharmacotherapyOpioid Substitution TherapyPooled AnalysisAntiviral DrugPharmacologyOpioid Use DisorderHealth Sciences